Evozyne

📍 Chicago, United States🗓 Founded 2020👥 63 employees💰 Last funded Sep 2023
Biotechnology🌐 evozyne.com
Website LinkedIn
Evozyne combines evolution and deep learning technology to create highly functional novel proteins — Natural Machines™ — to solve longstanding challenges in therapeutics and sustainability. By amplifying a protein’s function based on the rules of nature, we address complex, high-impact problems. From developing life-changing patient treatments to making carbon capture a reality, Evozyne is committed to making a healthier, more sustainable world.
1
Total investors
0
Early stage
1
Mid stage
0
Late stage
2020
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
1
Frequently asked questions
Who invested in Evozyne?
Evozyne has 1 investors on record on gritt.io, 1 mid-stage.
When did Evozyne last raise funding?
The most recent investment in Evozyne recorded on gritt.io was in September 2023.
When was Evozyne founded?
Evozyne was founded in 2020.
What industry is Evozyne in?
Evozyne operates in Biotechnology. Find similar Biotechnology investors on gritt.io.
Where is Evozyne based?
Evozyne is headquartered in Chicago, United States.